High flow nasal cannula therapy versus standard oxygen therapy in bronchiolitis: a prospective randomized control trial
DOI:
https://doi.org/10.18203/2349-3291.ijcp20242021Keywords:
Bronchiolitis, Oxygen saturation, Respiratory rate, HFNCAbstract
Background: Bronchiolitis is most common respiratory infection in infants and treatment focuses on management of respiratory distress and hypoxia. The clinical effectiveness of HFNC therapy in bronchiolitis has been reported only in non-experimental observational studies and also there is scarcity of high-grade evidence about HFNC usage in bronchiolitis, hence we intend to study the effectiveness of HFNC in bronchiolitis through prospective randomized control study.
Methods: It is prospective randomized control trial conducted at pediatric ward/ ICU at department of paediatrics, Al Ameen medical college, Bijapur from January 2023 to April 2024 all children diagnosed as bronchiolitis aged between 2 to 24 months were included. All of study participants had thorough histories obtained, including demographic information, vital parameters including SaO2 in room air. (Clinical severity score) by modified Wood’s clinical asthma score (M-WCAS) at admission and 2nd hourly till oxygen support is completely weaned off. Treatment failure is defined as meeting ≥3 out of 4 clinical criteria: persistent tachycardia, tachypnea, hypoxemia and decision of escalation by treating doctor. Primary outcome was treatment failure and need of escalation of therapy.
Results: A total of 65 cases are randomized, among them 33 cases are allocated to standard oxygen therapy and 32 cases to high flow nasal cannula group. HFNC group showed lower proportion of treatment failure than standard oxygen therapy group (p<0.0005). Secondary outcomes are also compared with previous studies.
Conclusions: HFNC group showed lower proportions of treatment failure than standard oxygen therapy.
References
Bordley WC, Viswanathan M, King VJ, Sutton SF, Jackman AM, Sterling L, et al. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med. 2004;158(2):119-26.
Fitzgerald DA, Kilham HA. Bronchiolitis: assessment and evidence-based management. Med J Aust. 2004;180(8):399-404.
Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474-502.
Ricci V, Nunes VD, Murphy MS, Cunningham S. Bronchiolitis in children: summary of NICE guidance. Bmj. 2015;350:h2305.
American Academy of Pediatrics. Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118:1774-93.
Verma N, Lodha R, Kabra SK. Recent advances in management of bronchiolitis. Indian pediatrics, 2013;50(10):939-49.
Franklin D, Babl FE, Schlapbach LJ, Oakley E, Craig S, Neutze J, et al. A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis. N Engl J Med. 2018;378(12):1121-31
Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011(6):CD003123.
Zhang L, Mendoza‐Sassi RA, Wainwright C, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2017;(12):CD006458.
Mayfield S, Bogossian F, O'Malley L, Schibler A. High-flow nasal cannula oxygen therapy for infants with bronchiolitis: Pilot study. J Paediatr Child Health. 2014;50(5):373-8.
Keenan SP, Sinuff T, Cook DJ, Hill NS. Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med. 2004;32(12):2516-23.
Schibler A, Pham TM, Dunster KR, Foster K, Barlow A, Gibbons K, et al. Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Med. 2011;37(5):847-52.
Ten Brink F, Duke T, Evans J. High-flow nasal prong oxygen therapy or nasopharyngeal continuous positive airway pressure for children with moderate-to severe respiratory distress? Pediatr Critical Care Med. 2013;14(7):e326-31.
Lazner MR, Basu AP, Klonin H. Non-invasive ventilation for severe bronchiolitis: analysis and evidence. Pediatr Pulmonol. 2012;47(9):909-16.
Nolasco S, Manti S, Leonardi S, Vancheri C, Spicuzza L. High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children. Frontiers Med. 2022;9:920549.
Kepreotes E, Whitehead B, Attia J, Oldmeadow C, Collison A, Searles A, et al. High-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): an open, phase 4, randomised controlled trial. The Lancet. 2017;389(10072):930-9.
Guilbert TW, Morgan WJ, Zeiger RS, Bacharier LB, Boehmer SJ, Krawiec M, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol. 2004;114(6):1282-7.
Kulhalli P, Dakshayini JN, Ratageri VH, Shivanand I, Wari PK. Risk factors for bronchiolitis. Indian Academy Pediatr. 2020;7(2):79.
Nagayama Y, Tsubaki T, Nakayama S, Sawada K, Taguchi K, Tateno N, et al. Gender analysis in acute bronchiolitis due to respiratory syncytial virus. Pediatric Allergy Immunol. 2006;17(1):29-36.
Boezen HM, Jansen DF, Postma DS. Sex and gender differences in lung development and their clinical significance. Clin Chest Med. 2004;25(2):237-45
Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003;143(5):118-26
Milani GP, Plebani AM, Arturi E, Brusa D, Esposito S, Dell'Era L, et al. Using a high-flow nasal cannula provided superior results to low-flow oxygen delivery in moderate to severe bronchiolitis. Acta Paediatr. 2016;105(8):e368-72.
